Table 1 Patients’ characteristics and clinical data (Groups with significant differences are marked by an asterisk; one-way ANOVA)

Total number (N)

9

17

23

3

10

32

Male (N)

3

11

13

2

6

18

Female (N)

6

6

10

1

4

14

Age (Yrs.)

25–53

29–71

26–66

48–58

45–59

23–72

Body mass index (kg/m²)

22.47 ± 2.52*

28.36 ± 1.10*

35.00 ± 3.45*

25.47 ± 0.34

27.87 ± 1.70

33.69 ± 2.55

Body fat percentage

27.73 ± 6.09

33.04 ± 4.95

39.09 ± 4.29

32.10 ± 6.22

31.29 ± 6.08

37.33 ± 5.04

Glucose (mmol/L)

4.94 ± 0.72

5.69 ± 1.63

5.24 ± 0.71

5.80 ± 0.42

9.04 ± 2.22

8.71 ± 2.91

Cholesterol (mmol/L)

5.53 ± 1.04

4.87 ± 0.81

5.05 ± 1.14

5.40 ± 2.55

4.91 ± 1.62

5.03 ± 1.23

High-density lipoprotein (mmol/L)

1.70 ± 0.48

1.20 ± 0.19

1.13 ± 0.24

1.14 ± 0.15

1.12 ± 0.40

1.15 ± 0.30

Low-density lipoprotein (mmol/L)

3.53 ± 0.92

3.14 ± 0.74

3.29 ± 1.01

3.70 ± 2.12

2.89 ± 1.37

2.98 ± 1.10

Triglycerides (mmol/L)

0.64 ± 0.25

1.18 ± 0.67

1.44 ± 0.89

1.25 ± 1.25

1.97 ± 0.83

1.89 ± 1.48

HbA1c (%)

5.74 ± 0.49

5.92 ± 1.70

5.68 ± 0.64

6.00 ± 0.28

7.91 ± 1.96

8.27 ± 1.50

Hypertension (N)

0

2

4

0

3

15

Hyperlipidemia (N)

0

0

1

0

2

4

Coronary artery disease (N)

0

0

1

0

1

1

Allergy (N)

0

0

1

0

0

2

Asthma (N)

1

1

0

0

0

3

Therapy

Ventolin

Nadolol, Zocor, Lipitor, Aspirin

Concor, Lipitor, Aspirin, Diovan, Zyloric

Metfornin, Aspirin

Glucophage, Lipitor, Lantus, Zocor, Diovan, NovoRapid, Metformin, Aspirin

NovoRapid, Lantus, Insulin, Aspirin, Concor, Zocor, Mixtard, Tenormin, Glucophage, Metformin, Capoten